JPWO2023282346A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023282346A5 JPWO2023282346A5 JP2022555691A JP2022555691A JPWO2023282346A5 JP WO2023282346 A5 JPWO2023282346 A5 JP WO2023282346A5 JP 2022555691 A JP2022555691 A JP 2022555691A JP 2022555691 A JP2022555691 A JP 2022555691A JP WO2023282346 A5 JPWO2023282346 A5 JP WO2023282346A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022178017A JP7466609B2 (ja) | 2021-07-08 | 2022-11-07 | 析出抑制剤 |
| JP2025126561A JP2025142303A (ja) | 2021-07-08 | 2025-07-29 | 析出抑制剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021113562 | 2021-07-08 | ||
| PCT/JP2022/027105 WO2023282346A1 (ja) | 2021-07-08 | 2022-07-08 | 析出抑制剤 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022178017A Division JP7466609B2 (ja) | 2021-07-08 | 2022-11-07 | 析出抑制剤 |
| JP2025126561A Division JP2025142303A (ja) | 2021-07-08 | 2025-07-29 | 析出抑制剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023282346A1 JPWO2023282346A1 (https=) | 2023-01-12 |
| JPWO2023282346A5 true JPWO2023282346A5 (https=) | 2023-09-19 |
Family
ID=84800729
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555691A Withdrawn JPWO2023282346A1 (https=) | 2021-07-08 | 2022-07-08 | |
| JP2022178017A Active JP7466609B2 (ja) | 2021-07-08 | 2022-11-07 | 析出抑制剤 |
| JP2025126561A Pending JP2025142303A (ja) | 2021-07-08 | 2025-07-29 | 析出抑制剤 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022178017A Active JP7466609B2 (ja) | 2021-07-08 | 2022-11-07 | 析出抑制剤 |
| JP2025126561A Pending JP2025142303A (ja) | 2021-07-08 | 2025-07-29 | 析出抑制剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240285770A1 (https=) |
| EP (1) | EP4368187A4 (https=) |
| JP (3) | JPWO2023282346A1 (https=) |
| KR (1) | KR20240035503A (https=) |
| CN (1) | CN118434424A (https=) |
| AU (1) | AU2022306542A1 (https=) |
| CA (1) | CA3225573A1 (https=) |
| IL (1) | IL310001A (https=) |
| TW (1) | TW202317147A (https=) |
| WO (1) | WO2023282346A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118475355A (zh) * | 2021-07-08 | 2024-08-09 | 日本新药株式会社 | 肾毒性减轻剂 |
| CA3225573A1 (en) * | 2021-07-08 | 2023-01-12 | Nippon Shinyaku Co., Ltd. | Precipitation suppressing agent |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU655164B2 (en) | 1989-12-20 | 1994-12-08 | Antivirals Inc. | Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages |
| WO2002036767A2 (en) | 2000-11-02 | 2002-05-10 | Inex Pharmaceuticals Corporation | Therapeutic oligonucleotides of reduced toxicity |
| WO2006038608A1 (ja) | 2004-10-05 | 2006-04-13 | Nippon Shinyaku Co., Ltd. | オリゴ二本鎖ｒｎａ及び医薬組成物 |
| JP2008520600A (ja) * | 2004-11-19 | 2008-06-19 | ノヴォソム アクチェンゲゼルシャフト | 局所投与のための医薬組成物におけるまたはそれに関する改善 |
| EP1886688A4 (en) | 2005-05-30 | 2013-01-09 | Nippon Shinyaku Co Ltd | METHOD FOR PRODUCING PREPARATION OF A NUCLEIC ACID-CONTAINING COMPLEX |
| PL2735568T3 (pl) | 2006-05-10 | 2018-02-28 | Sarepta Therapeutics, Inc. | Analogi oligonukleotydowe mające kationowe połączenia pomiędzy podjednostkami |
| CN1868456A (zh) * | 2006-06-25 | 2006-11-29 | 沈阳药科大学 | 反义脱氧寡核苷酸isis23665脂质体制剂及制备方法 |
| WO2009005793A2 (en) | 2007-06-29 | 2009-01-08 | Avi Biopharma, Inc. | Tissue specific peptide conjugates and methods |
| RU2606627C2 (ru) | 2007-11-15 | 2017-01-10 | Серепта Терапьютикс,Инк. | Способ синтеза морфолиновых олигомеров |
| WO2009073809A2 (en) | 2007-12-04 | 2009-06-11 | Alnylam Pharmaceuticals, Inc. | Carbohydrate conjugates as delivery agents for oligonucleotides |
| NZ589262A (en) * | 2008-07-18 | 2012-05-25 | Oncogenex Technologies Inc | Antisense formulation |
| CA3092114A1 (en) | 2011-05-05 | 2012-11-08 | Sarepta Therapeutics, Inc. | Peptide oligonucleotide conjugates |
| CN102989007B (zh) * | 2011-06-29 | 2015-12-16 | 湖州市中心医院 | 大规模制备注射用中期因子反义寡核苷酸纳米脂质体的方法 |
| EP3730618A1 (en) | 2011-11-18 | 2020-10-28 | Alnylam Pharmaceuticals, Inc. | Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases |
| CA2861247C (en) | 2011-12-28 | 2021-11-16 | Nippon Shinyaku Co., Ltd. | Antisense nucleic acids |
| DK2992098T3 (da) | 2013-05-01 | 2019-06-17 | Ionis Pharmaceuticals Inc | Sammensætninger og fremgangsmåder til modulering af hbv- og ttr-ekspression |
| WO2015006740A2 (en) | 2013-07-11 | 2015-01-15 | Alnylam Pharmaceuticals, Inc. | Oligonucleotide-ligand conjugates and process for their preparation |
| JP6519842B2 (ja) | 2013-10-04 | 2019-05-29 | 国立大学法人神戸大学 | 福山型筋ジストロフィー治療用アンチセンス核酸 |
| BR112016013516A8 (pt) | 2013-12-12 | 2020-05-19 | Life Technologies Corp | complexo de transfecção e seu uso para aumentar transporte de molécula de carga em células e para o tratamento de câncer e terapia gênica, bem como método in vitro para fornecer um poliânion a uma célula |
| JP6482475B2 (ja) | 2014-01-07 | 2019-03-13 | レナセラピューティクス株式会社 | アンチセンスオリゴヌクレオチド及び糖誘導体を含む二本鎖オリゴヌクレオチド |
| AU2016264471B2 (en) | 2015-05-19 | 2022-01-27 | Sarepta Therapeutics, Inc. | Peptide oligonucleotide conjugates |
| WO2017010575A1 (ja) | 2015-07-16 | 2017-01-19 | 協和発酵キリン株式会社 | β２ＧＰＩ遺伝子発現抑制核酸複合体 |
| KR102810425B1 (ko) | 2016-12-19 | 2025-05-21 | 사렙타 쎄러퓨틱스 인코퍼레이티드 | 근육 이상증에 대한 엑손 스킵핑 올리고머 결합체 |
| PT3554552T (pt) | 2016-12-19 | 2022-10-03 | Sarepta Therapeutics Inc | Conjugados de oligómero de skipping de exão para distrofia muscular |
| KR20240006023A (ko) | 2016-12-19 | 2024-01-12 | 사렙타 쎄러퓨틱스 인코퍼레이티드 | 근육 이상증에 대한 엑손 스킵핑 올리고머 결합체 |
| CA3225573A1 (en) * | 2021-07-08 | 2023-01-12 | Nippon Shinyaku Co., Ltd. | Precipitation suppressing agent |
| CN118475355A (zh) * | 2021-07-08 | 2024-08-09 | 日本新药株式会社 | 肾毒性减轻剂 |
-
2022
- 2022-07-08 CA CA3225573A patent/CA3225573A1/en active Pending
- 2022-07-08 JP JP2022555691A patent/JPWO2023282346A1/ja not_active Withdrawn
- 2022-07-08 IL IL310001A patent/IL310001A/en unknown
- 2022-07-08 AU AU2022306542A patent/AU2022306542A1/en active Pending
- 2022-07-08 US US18/577,142 patent/US20240285770A1/en active Pending
- 2022-07-08 CN CN202280047891.9A patent/CN118434424A/zh active Pending
- 2022-07-08 KR KR1020247003689A patent/KR20240035503A/ko active Pending
- 2022-07-08 WO PCT/JP2022/027105 patent/WO2023282346A1/ja not_active Ceased
- 2022-07-08 TW TW111125775A patent/TW202317147A/zh unknown
- 2022-07-08 EP EP22837760.2A patent/EP4368187A4/en active Pending
- 2022-11-07 JP JP2022178017A patent/JP7466609B2/ja active Active
-
2025
- 2025-07-29 JP JP2025126561A patent/JP2025142303A/ja active Pending